京尼平对肾癌细胞解偶联蛋白2及线粒体能量代谢的作用Effect of Genipin on Renal Cell Carcinoma and Research on the UCP2 and Uncouple Index
王楠,谷江,张永春,杨永安,朱致晖,杨清滔,沈俊,祝庆亮
WANG Nan1,GU Jiang1,ZHANG Yongchun1,YANG Yongan1,ZHU Zhihui1, YANG Qingtao1,SHEN Jun1,ZHU Qingliang2(1.Department of Urology Surgery
摘要(Abstract):
目的:探讨京尼平对肾癌细胞株(GRC-1)的作用及对解偶联蛋白2和线粒体能量代谢的影响。方法:使用不同剂量京尼平干预GRC-1后,应用MTT法检测细胞增殖和凋亡情况;使用RT-PCR法检测UCP2 mR-NA表达水平;收集细胞,检测细胞内ATP含量;提取线粒体,使用荧光分光光度计检测吸光度的变化,间接反映线粒体膜通透性转运孔开放程度。结果:随着京尼平剂量的增高,GRC-1细胞的抑制率逐渐升高,与对照组相比,中、高剂量京尼平组细胞的抑制率明显升高(P<0.05),UCP2的表达下调,UCP2 mRNA在高剂量京尼平组中的表达明显降低(P<0.05),且中、高剂量组线粒体内ATP含量下降(P<0.05),中、高剂量组线粒体膜通透性转运孔开放程度显著提高(P<0.001)。结论:京尼平可明显抑制肾癌细胞株的增殖,降低UCP2表达水平并对线粒体能量代谢产生影响。
Objective: To investigate the effect of genipin on the apoptosis of kidney cancer cell line represented by GRC-1,UCP2,and mitochondrial energy metabolism.Methods: GRC-1 was treated by genipin at different doses,and its proliferation and apoptosis were detected by MTT assay.RT-PCR was used to assess the expression levels of UCP2 mRNA.ATP content in GRC-1 was measured,and mitochondria were extracted.Fluorospectrophotometer was adopted to test the absorbance which could reflect membrane permeability of mitochondria.Results: As comparing with those in control group,apoptosis rate of GRC-1 cells in medium and high genipin groups increased obviously(P<0.001).while UCP2 mRNA expression level reduced.ATP amounts,and mitochondrion optical density in medium and high genipin groups were significantly lower than those in control group(P<0.05).Conclusion: Genipin could inhibit GRC-1 growth obviously,of which the mechanism might be the decrease of UCP2 expression and the influence on mitochondrial energy metabolism.
关键词(KeyWords):
京尼平;肾;癌;细胞;线粒体;能量代谢
genipin;kidney;carcinoma;cells;mitochondria;energy metabolism
基金项目(Foundation): 贵州省科技厅社会攻关计划项目,黔科合sy字[2011]3060;; 贵阳市科技计划项目,筑科合同[2011103]号
作者(Author):
王楠,谷江,张永春,杨永安,朱致晖,杨清滔,沈俊,祝庆亮
WANG Nan1,GU Jiang1,ZHANG Yongchun1,YANG Yongan1,ZHU Zhihui1, YANG Qingtao1,SHEN Jun1,ZHU Qingliang2(1.Department of Urology Surgery
DOI: 10.19367/j.cnki.1000-2707.2013.01.010
参考文献(References):
- [1]闫东.肾癌术后的生物免疫治疗新进展[J].现代泌尿外科杂志,2012(4):422-424.
- [2]Escudier B,Eisen T,Stadler WM,et al.Sorafenib in ad-vanced clear-cell renal cell carcinoma[J].N Engl JMed,2007(2):125-134.
- [3]马建辉.晚期肾癌靶向治疗临床研究现状[J].实用肿瘤杂志,2010(3):257-260.
- [4]Hye A,Byung AB.Mixed lineage kinase 3 connects reac-tive oxygen species to c-Jun NH2-terminal kinase inducedmitochondrial apoptosis in genipin-reated PC3 humanprostate cancer cells[J].Biochemical and BiophysicalResearch Communications,2007(362):307-312.
- [5]张红杰,施瑞华,罗云,等.解偶联蛋白2在结肠肿瘤发生发展中的作用研究[J].中华消化杂志,2011,31(12):808-811.
- [6]Brand MD,Affourtit C,Esteves TC,et al.Mitochondrialsuperoxide:production,biological effects,and activationof uncoupling proteins[J].Free Radic Biol Med,2004(37):755-767.
- [7]Sanchis D,Busquets S,Alvarez B,et al.Skeletal muscleUCP2 and UCP3 gene expression in a rat cancer cachexiamodel[J].FEBS Letters,1998(3):415-418.
- [8]邓三明.UCP2在非小细胞肺癌中表达与缺氧关系的探讨[D].西安:第四军医大学.
- [9]曹蕊,吴雄志.中药对肿瘤细胞周期影响的研究进展[J].中国肿瘤临床,2012(10):749-752.
- [10]CY Zhang,LE Parton,CP Ye,et al.Genipin inhibitsUCP2-mediated proton leak and acutely reverses obesity-and high glucose-inducedβcell dysfunction in isolatedpancreatic islets[J].Cell Metabolism,2006(6):417-427.
- [11]Esteves TC,Brand MD.The reactions catalyesed by themitochondrial uncoupling proteins UCP2 and UCP3[J].Biochim Biophys Acta,2005(1):35-44.
- [12]Takeda M,Shirato I,Kobayashi M,et al.Hydrogen per-oxide induces necrosis apoptosis,on-cosis and apoptoticoncosisi of mouse terminal proximal straight tubule cells[J].Nephron,1999(2):234-238.
- [13]姚志文,孙高慧,段磊,等.Genipin对糖尿病小鼠下丘脑细胞凋亡指数及解偶联蛋白2表达的影响[J].临床神经病学杂志,2012(2):123-125.
- [14]宋璐璐,萧建中,杨文英,等.京尼平抑制饱和脂肪酸诱导的HepG2细胞凋亡和内质网应激[J].国际内分泌代谢杂志,2011(2):80-83.
文章评论(Comment):
|
||||||||||||||||||
|
||||||||||||||||||
- 王楠
- 谷江
- 张永春
- 杨永安
- 朱致晖
- 杨清滔
- 沈俊
- 祝庆亮
WANG Nan1 - GU Jiang1
- ZHANG Yongchun1
- YANG Yongan1
- ZHU Zhihui1
- YANG Qingtao1
- SHEN Jun1
- ZHU Qingliang2(1.Department of Urology Surgery
- 王楠
- 谷江
- 张永春
- 杨永安
- 朱致晖
- 杨清滔
- 沈俊
- 祝庆亮
WANG Nan1 - GU Jiang1
- ZHANG Yongchun1
- YANG Yongan1
- ZHU Zhihui1
- YANG Qingtao1
- SHEN Jun1
- ZHU Qingliang2(1.Department of Urology Surgery